This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Varsanyi, T M Articles by Norrby, E Search for Related Content PubMed PubMed Citation Articles by Varsanyi, T M Articles by Norrby, E

 Previous Article  |  Next Article 

J Virol. 1987 December; 61(12): 3896-3901

Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

Department of Virology, School of Medicine, Karolinska Institute, Stockholm, Sweden.

ABSTRACT

The importance of each of the two surface glycoproteins of measles virus in active and passive immunization was examined in mice. Infected-cell lysates were depleted of either the hemagglutinin (H) or fusion (F) glycoprotein by using multiple cycles of immunoaffinity chromatography. The products were used to prepare immune-stimulating complexes (iscoms) containing either F or H glycoprotein. Such complexes are highly immunogenic, possibly as a result of effective presentation of viral proteins to the immune system [B. Morein, B. Sundquist, S. Höglund, K. Dalsgaard, and A. Osterhaus, Nature (London) 308:457-460, 1984]. Groups of 3-week-old BALB/c mice were inoculated with the iscom preparations. All animals developed hemolysis-inhibiting antibodies, whereas only sera of animals immunized with the iscoms containing the H glycoprotein had hemagglutination-inhibiting antibodies. Sera from animals immunized with the H or F preparation only precipitated the homologous glycoprotein in radioimmune precipitation assays. The immunized animals were challenged with a lethal dose of the hamster neurotropic variant of measles virus. Of the 7-week-old animals in the nonimmunized control group, 50% died within 10 days after challenge. No animals in the immunized groups showed symptoms of disease throughout the observation period of 3 months. Passive administration of anti-H monoclonal antibodies gave full protection against the 100% lethal acute infection with the hamster neurotropic variant of measles virus in newborn mice, whereas anti-F monoclonal antibodies failed to protect the animals. This study emphasizes that both H and F glycoproteins need to be considered in the development of measles virus subunit vaccines.

This article has been cited by other articles:

• Santibanez, S., Niewiesk, S., Heider, A., Schneider-Schaulies, J., Berbers, G. A. M., Zimmermann, A., Halenius, A., Wolbert, A., Deitemeier, I., Tischer, A., Hengel, H. (2005). Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?. J. Gen. Virol. 86: 365-374 [Abstract] [Full Text]  
• Verardi, P. H., Aziz, F. H., Ahmad, S., Jones, L. A., Beyene, B., Ngotho, R. N., Wamwayi, H. M., Yesus, M. G., Egziabher, B. G., Yilma, T. D. (2002). Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins. J. Virol. 76: 484-491 [Abstract] [Full Text]  
• de Carvalho Nicacio, C., Williamson, R. A., Parren, P. W. H. I., Lundkvist, A., Burton, D. R., Bjorling, E. (2002). Neutralizing Human Fab Fragments against Measles Virus Recovered by Phage Display. J. Virol. 76: 251-258 [Abstract] [Full Text]  
• Bouche, F., Ammerlaan, W., Berthet, F., Houard, S., Schneider, F., Muller, C. P. (1998). Immunosorbent Assay Based on Recombinant Hemagglutinin Protein Produced in a High-Efficiency Mammalian Expression System for Surveillance of Measles Immunity. J. Clin. Microbiol. 36: 721-726 [Abstract] [Full Text]